Hirsutism: Metabolic effects of two commonly used oral contraceptives and spironolactone

Robert A. Wild, Lawrence M. Demers, Deborah Applebaum-Bowden, Rosanna Lenker

Research output: Contribution to journalArticle

23 Scopus citations

Abstract

Fifty-one hirsute women were randomly treated for nine months with ethinyl estradiol 35 ug plus norethindrone 0.4 mg or 30 ug ethinyl estradiol plus 1.5 mg norethindrone acetate if they needed contraception or spironolactone 200 mg daily if they did not. Metabolic evaluations in response to therapy demonstrated triglyceride elevations with the two oral contraceptives but not with spironolactone. While systolic blood pressure was lower with spironolactone, fasting insulin levels were higher as opposed to either low-dose oral contraceptive preparation. Ethinyl estradiol 30 ug plus 1.5 mg norethindrone acetate lowered 3-alpha-diol glucuronide levels, yet ethinyl estradiol 35 ug plus norethindrone 0.4 mg and spironolactone were more effective in lowering Ferriman-Gallwey Scores. Treatment strategies for hirsute women need to consider metabolic consequences as well as efficacy.

Original languageEnglish (US)
Pages (from-to)113-124
Number of pages12
JournalContraception
Volume44
Issue number2
DOIs
Publication statusPublished - Aug 1991

    Fingerprint

All Science Journal Classification (ASJC) codes

  • Reproductive Medicine
  • Obstetrics and Gynecology

Cite this